missing translation for 'onlineSavingsMsg'
Learn More
Learn More
TRAP220/MED1 Antibody, Alexa Fluor™ 594, Novus Biologicals™
Rabbit Polyclonal Antibody
Brand: Novus Biologicals NB100-2574AF594
This item is not returnable.
View return policy
Description
TRAP220/MED1 Polyclonal specifically detects TRAP220/MED1 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin, Knockdown Validated.
Specifications
| TRAP220/MED1 | |
| Polyclonal | |
| Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin, Knockdown Validated | |
| Activator-recruited cofactor 205 kDa component, ARC205, CRSP1TRIP2, CRSP200p53 regulatory protein RB18A, DRIP230PPAR-binding protein, mediator complex subunit 1DRIP205, mediator of RNA polymerase II transcription subunit 1, PBPPPARGBP, Peroxisome proliferator-activated receptor-binding protein, PPAR binding protein, PPARBPMGC71488, PPARG binding protein, RB18ATR-interacting protein 2, Thyroid hormone receptor-associated protein complex 220 kDa component, thyroid hormone receptor-associated protein complex component TRAP220, thyroid receptor interacting protein 2, Thyroid receptor-interacting protein 2, Trap220, TRAP220TRIP-2, vitamin D receptor-interacting protein 230 kD, Vitamin D receptor-interacting protein complex component DRIP205 | |
| Rabbit | |
| Affinity Purified | |
| Cancer | |
| 5469.0 | |
| Store at 4°C in the dark. |
| Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin), KnockDown | |
| Alexa Fluor 594 | |
| 50 mM sodium borate with 0.05% sodium azide | |
| MED1 | |
| The immunogen recognized by this antibody maps to a region between residue 1525 and the C-terminus (residue 1581) of human Cofactor Required for Sp1 Transcriptional Activation 1using the numbering given in entry NP_004765.2 (GeneID 5469). | |
| 0.1 mL | |
| Primary | |
| Human, Mouse | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction